P1-146: A PROSPECTIVE, SYSTEMATIC LITERATURE REVIEW AND META-ANALYSES TO EVALUATE BRAIN AMYLOID BY POSITRON EMISSION TOMOGRAPHY (PET) IMAGING AS A BIOMARKER OF ALZHEIMER'S DISEASE (AD) PROGRESSION

Literature Review ◽

Systematic Literature Review ◽

Pet Imaging ◽

Emission Tomography ◽

Positron Emission ◽

Meta Analyses

Amyloid positron emission tomography (PET) imaging in the timely diagnosis of Alzheimer's disease

http://isrctn.com/ ◽

10.1186/isrctn17685148 ◽

2015 ◽

Author(s):

Naji Tabet

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Pet Imaging ◽

Emission Tomography ◽

Amyloid Positron Emission Tomography ◽

Timely Diagnosis ◽

Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease

Yearbook of Neurology and Neurosurgery ◽

10.1016/s0513-5117(08)79054-9 ◽

2008 ◽

Vol 2008 ◽

pp. 7-8

Author(s):

T.J. Grabowski

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Fluorodeoxyglucose Positron Emission

Cognitive Reserve ◽

Emission Tomography ◽

Fluorodeoxyglucose Positron Emission Tomography ◽

Pittsburgh Compound B ◽

Positron Emission ◽

Tau Positron Emission Tomography (PET) Longitudinal Substudy Associated With: Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers in the Treatment of Autosomal-Dominant Alzheimer's Disease

Case Medical Research ◽

10.31525/ct1-nct03977584 ◽

2019 ◽

Author(s):

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Autosomal Dominant Alzheimer’S Disease

Autosomal Dominant ◽

Emission Tomography ◽

Mutation Carriers ◽

Positron Emission ◽

Significant effects of cholinesterase inhibitors on tau pathology in the Alzheimer's disease continuum: An in vivo positron emission tomography study

International Journal of Geriatric Psychiatry ◽

10.1002/gps.5522 ◽

2021 ◽

Author(s):

Fumihiko Yasuno ◽

Hiroyuki Minami

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Cholinesterase Inhibitors ◽

Emission Tomography ◽

Positron Emission Tomography Study ◽

Tau Pathology ◽

The risk prediction of Alzheimer’s disease based on the deep learning model of brain 18F-FDG positron emission tomography

Saudi Journal of Biological Sciences ◽

10.1016/j.sjbs.2019.12.004 ◽

2020 ◽

Vol 27 (2) ◽

pp. 659-665

Author(s):

Zhiguang Yang ◽

Zhaoyu Liu

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Deep Learning ◽

Risk Prediction ◽

Learning Model ◽

Emission Tomography ◽

Positron Emission ◽

18F Fdg ◽

Deep Learning Model

Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: A positron emission tomography study

Annals of Neurology ◽

10.1002/1531-8249(200008)48:2<194::aid-ana9>3.0.co;2-x ◽

2000 ◽

Vol 48 (2) ◽

pp. 194-200 ◽

Cited By ~ 99

Author(s):

Hitoshi Shinotoh ◽

Hiroki Namba ◽

Kiyoshi Fukushi ◽

Shin-Ichiro Nagatsuka ◽

Noriko Tanaka ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Cognitive Decline ◽

Acetylcholinesterase Activity ◽

Emission Tomography ◽

Positron Emission Tomography Study ◽

Progressive Loss ◽

FP43-TH-03 [18 F]BAY 94–9172 positron emission tomography in the detection/exclusion of cerebral amyloid beta: an open-label, multicentre study in patients with probable Alzheimer's disease compared with healthy volunteers

Journal of the Neurological Sciences ◽

10.1016/s0022-510x(09)70497-6 ◽

2009 ◽

Vol 285 ◽

pp. S126

Author(s):

H. Barthel ◽

H.J. Gertz ◽

S. Dresel ◽

I. Heuser ◽

P. Bartenstein ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Multicentre Study ◽

Healthy Volunteers ◽

Amyloid Beta ◽

Emission Tomography ◽

Open Label ◽

Positron Emission ◽

Cerebral Amyloid

Fluorodeoxyglucose positron emission tomography: emerging roles in the evaluation of putative Alzheimer's disease-modifying treatments

Neurobiology of Aging ◽

10.1016/j.neurobiolaging.2011.09.007 ◽

2011 ◽

Vol 32 ◽

pp. S44-S47 ◽

Cited By ~ 18

Author(s):

Eric M. Reiman

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Fluorodeoxyglucose Positron Emission

Emission Tomography ◽

Fluorodeoxyglucose Positron Emission Tomography ◽

Positron Emission ◽

Disease Modifying ◽

Radiopharmaceuticals for positron emission tomography investigations of Alzheimer’s disease

European Journal of Nuclear Medicine and Molecular Imaging ◽

10.1007/s00259-009-1301-z ◽

2009 ◽

Vol 37 (8) ◽

pp. 1575-1593 ◽

Cited By ~ 21

Author(s):

Kjell Någren ◽

Christer Halldin ◽

Juha O. Rinne

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Emission Tomography ◽

A 4-Year Follow-Up of Subjects with Visually Equivocal Amyloid Positron Emission Tomography Findings from the Alzheimer’s Disease Neuroimaging Initiative Cohort

Nuclear Medicine and Molecular Imaging ◽

10.1007/s13139-021-00690-x ◽

2021 ◽

Author(s):

Minyoung Oh ◽

◽

Minjung Seo ◽

Sun Young Oh ◽

Heeyoung Kim ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Emission Tomography ◽

Amyloid Positron Emission Tomography ◽